Comparing Apixaban With Warfarin for Therapeutic Anticoagulation in Left Ventricular Assist Devices - 16/07/24
Doi : 10.1016/j.amjcard.2024.05.036
Cullen Soares, MD a, ⁎ 
, Yash Desai, MD a, Erik Sorensen, PhD b, Lynn Dees, MS c, Manjula Ananthram, MBBS a, Albert Hicks, MD, MPH a
, Yash Desai, MD a, Erik Sorensen, PhD b, Lynn Dees, MS c, Manjula Ananthram, MBBS a, Albert Hicks, MD, MPH a a Division of Cardiovascular Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland
b Division of Perioperative Services, Department of Surgery, University of Maryland Medical Center, Baltimore, Maryland
c Division of Cardiology, Department of Medicine, University of Maryland Medical Center, Baltimore, Maryland
⁎Corresponding author: Tel: 410-328-8278.
Keywords : heart failure, left ventricular assist device, warfarin, apixaban
Plan
| Funding: none. |
© 2024
Elsevier Inc. Tous droits réservés.
Vol 224
P. 14-16 - août 2024 Retour au numéro
Article précédent
- Enhanced External Counterpulsation Improves Long COVID–Associated Symptoms
- Jessie Fox, Monica Verduzco-Gutierrez, Steven Sanchez, Marielisa Lopez, Farhan Ali, Odayme Quesada, Timothy D. Henry, Sachin A. Shah
- Prevalence of Phenotypic Hypertrophic Cardiomyopathy Among Student Sports Participants
- Nicholas Roma, Rasha Aurshiya, Leyla Gasimli-Gamache, Spandan Desai, Bruce Ferraro, Maheep Vikram, Sudip Nanda, Jamshid Shirani
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?